Literature DB >> 10103294

Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.

E E Nolan1, K D Gadow, J Sprafkin.   

Abstract

OBJECTIVES: In this study we examined changes in attention-deficit hyperactivity disorder behaviors and motor and vocal tics during withdrawal from long-term maintenance therapy with stimulant medication.
METHODS: Subjects were 19 children with attention-deficit hyperactivity disorder and chronic tic disorder who had received methylphenidate (n = 17) or dextroamphetamine (n = 2) for a minimum of 1 year. Children were switched to placebo under double-blind conditions. Treatment effects were assessed by using direct observations of child behavior in a simulated (clinic-based) classroom and behavior rating scales completed by parents and clinician.
RESULTS: There was no change (group data) in the frequency or severity of motor tics or vocal tics during the placebo condition compared with maintenance dose of stimulant medication (ie, no evidence of tic exacerbation while receiving medication or of a withdrawal reaction). There was no evidence of tic exacerbation in the evening as a rebound effect. Treatment with the maintenance dose was also associated with behavioral improvement in attention-deficit hyperactivity disorder behaviors, indicating continued efficacy.
CONCLUSIONS: Abrupt withdrawal of stimulant medication in children receiving long-term maintenance therapy does not appear to result in worsening of tic frequency or severity. Nevertheless, these findings do not preclude the possibility of drug withdrawal reactions in susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103294     DOI: 10.1542/peds.103.4.730

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains.

Authors:  Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2006-10-19       Impact factor: 4.077

2.  Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.

Authors:  Jonathan R Stevens; Timothy E Wilens; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-28

Review 3.  Tourette syndrome: clinical characteristics and current management strategies.

Authors:  E H Kossoff; H S Singer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.

Authors:  Yu-Shu Huang; Ming-Horng Tsai
Journal:  CNS Drugs       Date:  2011-07       Impact factor: 5.749

Review 5.  Current research highlights in child and adolescent psychopharmacology.

Authors:  B Vitiello
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

Review 6.  Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management.

Authors:  Steven R Pliszka
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 7.  Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.

Authors:  Sydney T Osland; Thomas Dl Steeves; Tamara Pringsheim
Journal:  Cochrane Database Syst Rev       Date:  2018-06-26

Review 8.  Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder.

Authors:  Seok-Hyun Nam; Myung Ho Lim; Tae Won Park
Journal:  Soa Chongsonyon Chongsin Uihak       Date:  2022-04-01

9.  Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies.

Authors:  David W Goodman
Journal:  Ther Clin Risk Manag       Date:  2013-03-21       Impact factor: 2.423

Review 10.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.